Globus Medical Inc (GMED) stock
GMEDNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 22/3044% below fair value
$69.99−0.51 (-0.72%)
Close on Nov 17, 2026Market cap $9.40BP/E 17.9Yield –
Globus Medical ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Globus Medical's ebitda for the twelve months ending Jun 30, 2026 was $919.44M, up 66.5% year over year. For fiscal 2025 it was $756.66M, up 80.4% from the year before. Over ten years it grew 14.4% a year on average. The highest annual figure on record is $756.66M in fiscal 2025.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $756.66M | +80.4% |
| FY2024 | Dec 31, 2024 | $419.38M | +50.5% |
| FY2023 | Dec 31, 2023 | $278.67M | -5.9% |
| FY2022 | Dec 31, 2022 | $296.20M | +22.5% |
| FY2021 | Dec 31, 2021 | $241.82M | +38.7% |
| FY2020 | Dec 31, 2020 | $174.31M | -22.4% |
| FY2019 | Dec 31, 2019 | $224.72M | +6.5% |
| FY2018 | Dec 31, 2018 | $210.96M | +3.5% |
| FY2017 | Dec 31, 2017 | $203.91M | +5.7% |
| FY2016 | Dec 31, 2016 | $192.91M | -1.7% |
| FY2015 | Dec 31, 2015 | $196.31M | +22.6% |
| FY2014 | Dec 31, 2014 | $160.12M | +32.3% |
| FY2013 | Dec 31, 2013 | $121.07M | -8.9% |
| FY2012 | Dec 31, 2012 | $132.90M | +16.3% |
| FY2011 | Dec 31, 2011 | $114.31M | +11.1% |
| FY2010 | Dec 31, 2010 | $102.88M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $251.93M | +71.7% |
| Q1 FY2026 | Mar 31, 2026 | $220.24M | +35.4% |
| Q4 FY2025 | Dec 31, 2025 | $238.35M | +86.4% |
| Q3 FY2025 | Sep 30, 2025 | $208.91M | +81.6% |
| Q2 FY2025 | Jun 30, 2025 | $146.74M | +29.6% |
| Q1 FY2025 | Mar 31, 2025 | $162.66M | +157.1% |
| Q4 FY2024 | Dec 31, 2024 | $127.87M | +55.8% |
| Q3 FY2024 | Sep 30, 2024 | $115.05M | +204.4% |
| Q2 FY2024 | Jun 30, 2024 | $113.21M | +34.3% |
| Q1 FY2024 | Mar 31, 2024 | $63.26M | -15.1% |
| Q4 FY2023 | Dec 31, 2023 | $82.08M | +15.7% |
| Q3 FY2023 | Sep 30, 2023 | $37.79M | -51.1% |
| Q2 FY2023 | Jun 30, 2023 | $84.29M | -0.5% |
| Q1 FY2023 | Mar 31, 2023 | $74.51M | +17.7% |
| Q4 FY2022 | Dec 31, 2022 | $70.94M | +102.5% |
| Q3 FY2022 | Sep 30, 2022 | $77.28M | +10.3% |
| Q2 FY2022 | Jun 30, 2022 | $84.70M | +30.3% |
| Q1 FY2022 | Mar 31, 2022 | $63.28M | -11.7% |
| Q4 FY2021 | Dec 31, 2021 | $35.03M | -53.6% |
| Q3 FY2021 | Sep 30, 2021 | $70.08M | +5.7% |
| Q2 FY2021 | Jun 30, 2021 | $65.01M | – |
| Q1 FY2021 | Mar 31, 2021 | $71.71M | +66.7% |
| Q4 FY2020 | Dec 31, 2020 | $75.44M | +17.8% |
| Q3 FY2020 | Sep 30, 2020 | $66.31M | +19.2% |
| Q2 FY2020 | Jun 30, 2020 | -$10.46M | -118.8% |
| Q1 FY2020 | Mar 31, 2020 | $43.02M | -12.8% |
| Q4 FY2019 | Dec 31, 2019 | $64.03M | – |
| Q3 FY2019 | Sep 30, 2019 | $55.64M | -8.3% |
| Q2 FY2019 | Jun 30, 2019 | $55.73M | +7.4% |
| Q1 FY2019 | Mar 31, 2019 | $49.33M | -10.5% |
| Q4 FY2018 | Dec 31, 2018 | $0 | -100.0% |
| Q3 FY2018 | Sep 30, 2018 | $60.70M | +30.2% |
| Q2 FY2018 | Jun 30, 2018 | $51.90M | +8.0% |
| Q1 FY2018 | Mar 31, 2018 | $55.11M | +4.9% |
| Q4 FY2017 | Dec 31, 2017 | $56.65M | +7.0% |
| Q3 FY2017 | Sep 30, 2017 | $46.63M | +2.5% |
| Q2 FY2017 | Jun 30, 2017 | $48.07M | – |
| Q1 FY2017 | Mar 31, 2017 | $52.55M | – |
| Q4 FY2016 | Dec 31, 2016 | $52.96M | – |
| Q3 FY2016 | Sep 30, 2016 | $45.49M | – |
See a number that looks wrong?